The global market for Covid-19 Diagnostic was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Covid-19 Diagnostic, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Covid-19 Diagnostic by region & country, by Type, and by Application.
The Covid-19 Diagnostic market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Diagnostic.
麻豆原创 Segmentation
By Company
Abbott Diagnostics
Accelerate Diagnostics
Ador Diagnostics
Akkoni Biosystems
Alveo Technologies
Applied BioCode
Aus Diagnostics
BD Diagnostics
Biocartis
BioFire Diagnostics
产颈辞惭茅谤颈别耻虫
Bio-Rad Laboratories
Bosch Healthcare Solutions GmbH
Cepheid
Co-Diagnostics
Cue Health
Curetis
Diagenode Diagnostics
Diascopic
Diasorin
Expedeon
Fusion Genomics.
GenePOC Diagnostics
GenMark Dx
Hologic
Immunexpress
Inflammatix
Invetech
Janssen Diagnostics
Segment by Type:
Immunoassay
Genomic and WGS Role
rRT-PCR
Segment by Application
Hospital
Laboratory
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Covid-19 Diagnostic manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Covid-19 Diagnostic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Covid-19 Diagnostic in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Covid-19 Diagnostic Product Introduction
1.2 Global Covid-19 Diagnostic 麻豆原创 Size Forecast
1.3 Covid-19 Diagnostic 麻豆原创 Trends & Drivers
1.3.1 Covid-19 Diagnostic Industry Trends
1.3.2 Covid-19 Diagnostic 麻豆原创 Drivers & Opportunity
1.3.3 Covid-19 Diagnostic 麻豆原创 Challenges
1.3.4 Covid-19 Diagnostic 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Covid-19 Diagnostic Players Revenue Ranking (2023)
2.2 Global Covid-19 Diagnostic Revenue by Company (2019-2024)
2.3 Key Companies Covid-19 Diagnostic Manufacturing Base Distribution and Headquarters
2.4 Key Companies Covid-19 Diagnostic Product Offered
2.5 Key Companies Time to Begin Mass Production of Covid-19 Diagnostic
2.6 Covid-19 Diagnostic 麻豆原创 Competitive Analysis
2.6.1 Covid-19 Diagnostic 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Covid-19 Diagnostic Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Diagnostic as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Immunoassay
3.1.2 Genomic and WGS Role
3.1.3 rRT-PCR
3.2 Global Covid-19 Diagnostic Sales Value by Type
3.2.1 Global Covid-19 Diagnostic Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Covid-19 Diagnostic Sales Value, by Type (2019-2030)
3.2.3 Global Covid-19 Diagnostic Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Laboratory
4.2 Global Covid-19 Diagnostic Sales Value by Application
4.2.1 Global Covid-19 Diagnostic Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Covid-19 Diagnostic Sales Value, by Application (2019-2030)
4.2.3 Global Covid-19 Diagnostic Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Covid-19 Diagnostic Sales Value by Region
5.1.1 Global Covid-19 Diagnostic Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Covid-19 Diagnostic Sales Value by Region (2019-2024)
5.1.3 Global Covid-19 Diagnostic Sales Value by Region (2025-2030)
5.1.4 Global Covid-19 Diagnostic Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Covid-19 Diagnostic Sales Value, 2019-2030
5.2.2 North America Covid-19 Diagnostic Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Covid-19 Diagnostic Sales Value, 2019-2030
5.3.2 Europe Covid-19 Diagnostic Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Covid-19 Diagnostic Sales Value, 2019-2030
5.4.2 Asia Pacific Covid-19 Diagnostic Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Covid-19 Diagnostic Sales Value, 2019-2030
5.5.2 South America Covid-19 Diagnostic Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Covid-19 Diagnostic Sales Value, 2019-2030
5.6.2 Middle East & Africa Covid-19 Diagnostic Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Covid-19 Diagnostic Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Covid-19 Diagnostic Sales Value
6.3 United States
6.3.1 United States Covid-19 Diagnostic Sales Value, 2019-2030
6.3.2 United States Covid-19 Diagnostic Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Covid-19 Diagnostic Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Covid-19 Diagnostic Sales Value, 2019-2030
6.4.2 Europe Covid-19 Diagnostic Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Covid-19 Diagnostic Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Covid-19 Diagnostic Sales Value, 2019-2030
6.5.2 China Covid-19 Diagnostic Sales Value by Type (%), 2023 VS 2030
6.5.3 China Covid-19 Diagnostic Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Covid-19 Diagnostic Sales Value, 2019-2030
6.6.2 Japan Covid-19 Diagnostic Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Covid-19 Diagnostic Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Covid-19 Diagnostic Sales Value, 2019-2030
6.7.2 South Korea Covid-19 Diagnostic Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Covid-19 Diagnostic Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Covid-19 Diagnostic Sales Value, 2019-2030
6.8.2 Southeast Asia Covid-19 Diagnostic Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Covid-19 Diagnostic Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Covid-19 Diagnostic Sales Value, 2019-2030
6.9.2 India Covid-19 Diagnostic Sales Value by Type (%), 2023 VS 2030
6.9.3 India Covid-19 Diagnostic Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Diagnostics
7.1.1 Abbott Diagnostics Profile
7.1.2 Abbott Diagnostics Main Business
7.1.3 Abbott Diagnostics Covid-19 Diagnostic Products, Services and Solutions
7.1.4 Abbott Diagnostics Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Diagnostics Recent Developments
7.2 Accelerate Diagnostics
7.2.1 Accelerate Diagnostics Profile
7.2.2 Accelerate Diagnostics Main Business
7.2.3 Accelerate Diagnostics Covid-19 Diagnostic Products, Services and Solutions
7.2.4 Accelerate Diagnostics Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.2.5 Accelerate Diagnostics Recent Developments
7.3 Ador Diagnostics
7.3.1 Ador Diagnostics Profile
7.3.2 Ador Diagnostics Main Business
7.3.3 Ador Diagnostics Covid-19 Diagnostic Products, Services and Solutions
7.3.4 Ador Diagnostics Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.3.5 Akkoni Biosystems Recent Developments
7.4 Akkoni Biosystems
7.4.1 Akkoni Biosystems Profile
7.4.2 Akkoni Biosystems Main Business
7.4.3 Akkoni Biosystems Covid-19 Diagnostic Products, Services and Solutions
7.4.4 Akkoni Biosystems Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.4.5 Akkoni Biosystems Recent Developments
7.5 Alveo Technologies
7.5.1 Alveo Technologies Profile
7.5.2 Alveo Technologies Main Business
7.5.3 Alveo Technologies Covid-19 Diagnostic Products, Services and Solutions
7.5.4 Alveo Technologies Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.5.5 Alveo Technologies Recent Developments
7.6 Applied BioCode
7.6.1 Applied BioCode Profile
7.6.2 Applied BioCode Main Business
7.6.3 Applied BioCode Covid-19 Diagnostic Products, Services and Solutions
7.6.4 Applied BioCode Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.6.5 Applied BioCode Recent Developments
7.7 Aus Diagnostics
7.7.1 Aus Diagnostics Profile
7.7.2 Aus Diagnostics Main Business
7.7.3 Aus Diagnostics Covid-19 Diagnostic Products, Services and Solutions
7.7.4 Aus Diagnostics Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.7.5 Aus Diagnostics Recent Developments
7.8 BD Diagnostics
7.8.1 BD Diagnostics Profile
7.8.2 BD Diagnostics Main Business
7.8.3 BD Diagnostics Covid-19 Diagnostic Products, Services and Solutions
7.8.4 BD Diagnostics Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.8.5 BD Diagnostics Recent Developments
7.9 Biocartis
7.9.1 Biocartis Profile
7.9.2 Biocartis Main Business
7.9.3 Biocartis Covid-19 Diagnostic Products, Services and Solutions
7.9.4 Biocartis Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.9.5 Biocartis Recent Developments
7.10 BioFire Diagnostics
7.10.1 BioFire Diagnostics Profile
7.10.2 BioFire Diagnostics Main Business
7.10.3 BioFire Diagnostics Covid-19 Diagnostic Products, Services and Solutions
7.10.4 BioFire Diagnostics Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.10.5 BioFire Diagnostics Recent Developments
7.11 产颈辞惭茅谤颈别耻虫
7.11.1 产颈辞惭茅谤颈别耻虫 Profile
7.11.2 产颈辞惭茅谤颈别耻虫 Main Business
7.11.3 产颈辞惭茅谤颈别耻虫 Covid-19 Diagnostic Products, Services and Solutions
7.11.4 产颈辞惭茅谤颈别耻虫 Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.11.5 产颈辞惭茅谤颈别耻虫 Recent Developments
7.12 Bio-Rad Laboratories
7.12.1 Bio-Rad Laboratories Profile
7.12.2 Bio-Rad Laboratories Main Business
7.12.3 Bio-Rad Laboratories Covid-19 Diagnostic Products, Services and Solutions
7.12.4 Bio-Rad Laboratories Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.12.5 Bio-Rad Laboratories Recent Developments
7.13 Bosch Healthcare Solutions GmbH
7.13.1 Bosch Healthcare Solutions GmbH Profile
7.13.2 Bosch Healthcare Solutions GmbH Main Business
7.13.3 Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Products, Services and Solutions
7.13.4 Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.13.5 Bosch Healthcare Solutions GmbH Recent Developments
7.14 Cepheid
7.14.1 Cepheid Profile
7.14.2 Cepheid Main Business
7.14.3 Cepheid Covid-19 Diagnostic Products, Services and Solutions
7.14.4 Cepheid Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.14.5 Cepheid Recent Developments
7.15 Co-Diagnostics
7.15.1 Co-Diagnostics Profile
7.15.2 Co-Diagnostics Main Business
7.15.3 Co-Diagnostics Covid-19 Diagnostic Products, Services and Solutions
7.15.4 Co-Diagnostics Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.15.5 Co-Diagnostics Recent Developments
7.16 Cue Health
7.16.1 Cue Health Profile
7.16.2 Cue Health Main Business
7.16.3 Cue Health Covid-19 Diagnostic Products, Services and Solutions
7.16.4 Cue Health Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.16.5 Cue Health Recent Developments
7.17 Curetis
7.17.1 Curetis Profile
7.17.2 Curetis Main Business
7.17.3 Curetis Covid-19 Diagnostic Products, Services and Solutions
7.17.4 Curetis Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.17.5 Curetis Recent Developments
7.18 Diagenode Diagnostics
7.18.1 Diagenode Diagnostics Profile
7.18.2 Diagenode Diagnostics Main Business
7.18.3 Diagenode Diagnostics Covid-19 Diagnostic Products, Services and Solutions
7.18.4 Diagenode Diagnostics Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.18.5 Diagenode Diagnostics Recent Developments
7.19 Diascopic
7.19.1 Diascopic Profile
7.19.2 Diascopic Main Business
7.19.3 Diascopic Covid-19 Diagnostic Products, Services and Solutions
7.19.4 Diascopic Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.19.5 Diascopic Recent Developments
7.20 Diasorin
7.20.1 Diasorin Profile
7.20.2 Diasorin Main Business
7.20.3 Diasorin Covid-19 Diagnostic Products, Services and Solutions
7.20.4 Diasorin Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.20.5 Diasorin Recent Developments
7.21 Expedeon
7.21.1 Expedeon Profile
7.21.2 Expedeon Main Business
7.21.3 Expedeon Covid-19 Diagnostic Products, Services and Solutions
7.21.4 Expedeon Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.21.5 Expedeon Recent Developments
7.22 Fusion Genomics.
7.22.1 Fusion Genomics. Profile
7.22.2 Fusion Genomics. Main Business
7.22.3 Fusion Genomics. Covid-19 Diagnostic Products, Services and Solutions
7.22.4 Fusion Genomics. Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.22.5 Fusion Genomics. Recent Developments
7.23 GenePOC Diagnostics
7.23.1 GenePOC Diagnostics Profile
7.23.2 GenePOC Diagnostics Main Business
7.23.3 GenePOC Diagnostics Covid-19 Diagnostic Products, Services and Solutions
7.23.4 GenePOC Diagnostics Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.23.5 GenePOC Diagnostics Recent Developments
7.24 GenMark Dx
7.24.1 GenMark Dx Profile
7.24.2 GenMark Dx Main Business
7.24.3 GenMark Dx Covid-19 Diagnostic Products, Services and Solutions
7.24.4 GenMark Dx Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.24.5 GenMark Dx Recent Developments
7.25 Hologic
7.25.1 Hologic Profile
7.25.2 Hologic Main Business
7.25.3 Hologic Covid-19 Diagnostic Products, Services and Solutions
7.25.4 Hologic Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.25.5 Hologic Recent Developments
7.26 Immunexpress
7.26.1 Immunexpress Profile
7.26.2 Immunexpress Main Business
7.26.3 Immunexpress Covid-19 Diagnostic Products, Services and Solutions
7.26.4 Immunexpress Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.26.5 Immunexpress Recent Developments
7.27 Inflammatix
7.27.1 Inflammatix Profile
7.27.2 Inflammatix Main Business
7.27.3 Inflammatix Covid-19 Diagnostic Products, Services and Solutions
7.27.4 Inflammatix Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.27.5 Inflammatix Recent Developments
7.28 Invetech
7.28.1 Invetech Profile
7.28.2 Invetech Main Business
7.28.3 Invetech Covid-19 Diagnostic Products, Services and Solutions
7.28.4 Invetech Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.28.5 Invetech Recent Developments
7.29 Janssen Diagnostics
7.29.1 Janssen Diagnostics Profile
7.29.2 Janssen Diagnostics Main Business
7.29.3 Janssen Diagnostics Covid-19 Diagnostic Products, Services and Solutions
7.29.4 Janssen Diagnostics Covid-19 Diagnostic Revenue (US$ Million) & (2019-2024)
7.29.5 Janssen Diagnostics Recent Developments
8 Industry Chain Analysis
8.1 Covid-19 Diagnostic Industrial Chain
8.2 Covid-19 Diagnostic Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Covid-19 Diagnostic Sales Model
8.5.2 Sales Channel
8.5.3 Covid-19 Diagnostic Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Abbott Diagnostics
Accelerate Diagnostics
Ador Diagnostics
Akkoni Biosystems
Alveo Technologies
Applied BioCode
Aus Diagnostics
BD Diagnostics
Biocartis
BioFire Diagnostics
产颈辞惭茅谤颈别耻虫
Bio-Rad Laboratories
Bosch Healthcare Solutions GmbH
Cepheid
Co-Diagnostics
Cue Health
Curetis
Diagenode Diagnostics
Diascopic
Diasorin
Expedeon
Fusion Genomics.
GenePOC Diagnostics
GenMark Dx
Hologic
Immunexpress
Inflammatix
Invetech
Janssen Diagnostics
听
听
*If Applicable.
